Pellizzer GP - Search Results

1

Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008.

Prosperi MC, Cozzi-Lepri A, Antinori A, Cassola G, Torti C, Ursitti MA, Pellizzer GP, Giacometti A, d'Arminio Monforte A, De Luca A; Icona Foundation Study Group. Prosperi MC, et al. Among authors: pellizzer gp. HIV Med. 2011 Mar;12(3):174-82. doi: 10.1111/j.1468-1293.2010.00866.x. Epub 2010 Aug 18. HIV Med. 2011. PMID: 20726904 Free article.

2

Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy.

Zanone Poma B, Riva A, Nasi M, Cicconi P, Broggini V, Lepri AC, Mologni D, Mazzotta F, Monforte AD, Mussini C, Cossarizza A, Galli M; Icona Foundation Study Group. Zanone Poma B, et al. AIDS. 2008 Sep 12;22(14):1769-78. doi: 10.1097/QAD.0b013e32830b3a96. AIDS. 2008. PMID: 18753860

3

Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.

d'Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, Mussini C, Caputo SL, Arlotti M, Magnani G, Pellizzer G, Maggiolo F, Puoti M; Icona Foundation Study Group. d'Arminio Monforte A, et al. Clin Infect Dis. 2009 Aug 15;49(4):612-22. doi: 10.1086/603557. Clin Infect Dis. 2009. PMID: 19591597

4

Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients.

Cicconi P, Cozzi-Lepri A, Castagna A, Trecarichi EM, Antinori A, Gatti F, Cassola G, Sighinolfi L, Castelli P, d'Arminio Monforte A; ICoNA Foundation Study Group. Cicconi P, et al. HIV Med. 2010 Feb;11(2):104-13. doi: 10.1111/j.1468-1293.2009.00750.x. Epub 2009 Sep 1. HIV Med. 2010. PMID: 19732176 Free article.

5

Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina.

Podlekareva DN, Mocroft A, Post FA, Riekstina V, Miro JM, Furrer H, Bruyand M, Panteleev AM, Rakhmanova AG, Girardi E, Losso MH, Toibaro JJ, Caylá J, Miller RF, Obel N, Skrahina A, Chentsova N, Lundgren JD, Kirk O; HIV/TB Study Writing Group. Podlekareva DN, et al. AIDS. 2009 Nov 27;23(18):2485-95. doi: 10.1097/QAD.0b013e3283326879. AIDS. 2009. PMID: 19898216

6

High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.

Worm SW, Friis-Møller N, Bruyand M, D'Arminio Monforte A, Rickenbach M, Reiss P, El-Sadr W, Phillips A, Lundgren J, Sabin C; D:A:D study group. Worm SW, et al. AIDS. 2010 Jan 28;24(3):427-35. doi: 10.1097/QAD.0b013e328334344e. AIDS. 2010. PMID: 19910787

7

Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study.

Prosperi MC, Cozzi-Lepri A, Castagna A, Mussini C, Murri R, Giacometti A, Torti C, Costantini A, Narciso P, Ghinelli F, Antinori A, d'Arminio Monforte A; Icona Foundation Study Group. Prosperi MC, et al. Clin Infect Dis. 2010 May 1;50(9):1316-21. doi: 10.1086/651688. Clin Infect Dis. 2010. PMID: 20297953

8

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.

Friis-Møller N, Thiébaut R, Reiss P, Weber R, Monforte AD, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, Phillips A, Sabin CA, Lundgren JD, Law MG; DAD study group. Friis-Møller N, et al. Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):491-501. doi: 10.1097/HJR.0b013e328336a150. Eur J Cardiovasc Prev Rehabil. 2010. PMID: 20543702

9

Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure.

Tordato F, Cozzi Lepri A, Cicconi P, De Luca A, Antinori A, Colangeli V, Castagna A, Nasta P, Ladisa N, Giacometti A, d'Arminio Monforte A, Gori A; ICONA Foundation Study Group. Tordato F, et al. HIV Med. 2011 Jan;12(1):4-13. doi: 10.1111/j.1468-1293.2010.00855.x. HIV Med. 2011. PMID: 20584091 Free article.

10

Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count.

Marchetti G, Cozzi-Lepri A, Merlini E, Bellistrì GM, Castagna A, Galli M, Verucchi G, Antinori A, Costantini A, Giacometti A, di Caro A, D'arminio Monforte A; ICONA Foundation Study Group. Marchetti G, et al. AIDS. 2011 Jul 17;25(11):1385-94. doi: 10.1097/QAD.0b013e3283471d10. AIDS. 2011. PMID: 21505312

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters